#1075
August Troendle
Overview
- Source of Wealth
- Pharmaceutical services
- Industry
- Healthcare
- Residence
- Cincinnati, Ohio
- Education
- University of Maryland (Medical Doctor)
Assets
- Medpace5,392,144 shares @ --MEDP-US
- Medpace58,000 shares @ --MEDP-US
- Medpace93,174 shares @ --MEDP-US
- Medpace50,000 shares @ --MEDP-US
- Medpace73,443 shares @ --MEDP-US
Biography
August Troendle is the CEO of Medpace, a clinical research company he founded in Cincinnati, Ohio in 1992; he owns nearly 20% of the stock.
Medpace conducts clinical trials for pharmaceutical companies seeking to bring drugs, vaccines or medical devices to market.
Before starting Medpace, Troendle spent five years as a director at Swiss pharma company Sandoz, now known as Novartis.
He also briefly worked as a medical review officer at the FDA's division of metabolic and endocrine drug products from 1986 to 1987.
A doctor with an M.D. from the University of Maryland, Troendle has also served on the boards of several public and private healthcare companies.